P
Peter C Gøtzsche
Researcher at Cochrane Collaboration
Publications - 426
Citations - 191584
Peter C Gøtzsche is an academic researcher from Cochrane Collaboration. The author has contributed to research in topics: Clinical trial & Systematic review. The author has an hindex of 90, co-authored 413 publications receiving 147009 citations. Previous affiliations of Peter C Gøtzsche include University of Copenhagen & Copenhagen University Hospital.
Papers
More filters
Journal ArticleDOI
Breast cancer awareness month. Still awaiting screening facts.
Michael J. Baum,Hazel Thornton,Peter C Gøtzsche,Susan Bewley,Karsten Juhl Jørgensen,Alexandra Barratt,Nick Ross,Steven Woloshin,Lisa Schwartz,Toni Musiello,Mitzi Blennerhassett,Maryann Napoli,Cornelia J. Baines,Jayant S. Vaidya,Norman R. Williams,Daphne Havercroft,Per Henrik Zahl,Michael W. Retsky,Robert M. Kaplan,Mary Dixon-Woods,Donald A. Berry,Keith Isaacson,Diana Brahams,Miriam Pryke,Gillian Tindall,David A. Bender,Tom Marshall +26 more
TL;DR: On 19 February 2009 the authors wrote a letter in the Times calling for the leaflet, Breast Screening: the Facts , to be rewritten because none of the invitations for screening told the truth about its harms and benefits.
Journal Article
Review of dose-response studies of NSAIDs in rheumatoid arthritis.
TL;DR: Double-blind dose-response studies of aspirin, phenylbutazone, indomethacin, ibuprofen, naproxen, piroxicam, diclofenac, diflunisal, and tolfenamic acid showed an increase in effect obtained with the highest doses of the drugs, and as a general rule, NSAIDs should be used at the lower end of the recommended dose ranges.
Journal Article
Meta-analysis of grip strength: most common, but superfluous variable in comparative NSAID trials.
TL;DR: A meta-analysis was done on grip strength, the most common variable in comparative NSAID trials: even the drug effect over placebo was less than what most rheumatologists considered of relevance.
Journal ArticleDOI
The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder
Kim Boesen,Luis Carlos Saiz,Juan Erviti,Ole Jakob Storebø,Christian Gluud,Peter C Gøtzsche,Karsten Juhl Jørgensen +6 more
TL;DR: It is concluded that clinical trials of immediate-release methylphenidate in adults with ADHD are of very low quality and urgently need well-conducted long-term trials free of bias to assess the benefits and harms of central stimulant treatment in adult ADHD.
Journal ArticleDOI
Universal health checks should be abandoned
TL;DR: An eBulletin response to the Cochrane review on general health checks in adults found no benefit for morbidity and mortality from disease.